ADALIMUMAB-AACF for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 9 adverse event reports in the FDA FAERS database where ADALIMUMAB-AACF was used for Psoriasis.
Most Reported Side Effects for ADALIMUMAB-AACF
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Abdominal pain upper | 11 | 7.9% | 0 | 9 |
| Axial spondyloarthritis | 10 | 7.1% | 0 | 10 |
| Drug ineffective | 9 | 6.4% | 0 | 1 |
| Psoriatic arthropathy | 9 | 6.4% | 0 | 8 |
| Nasopharyngitis | 8 | 5.7% | 0 | 7 |
| Reactive gastropathy | 8 | 5.7% | 0 | 8 |
| Spinal osteoarthritis | 8 | 5.7% | 0 | 8 |
| Arthralgia | 7 | 5.0% | 0 | 2 |
| Benign prostatic hyperplasia | 6 | 4.3% | 0 | 4 |
| Pain | 6 | 4.3% | 0 | 0 |
| Rheumatoid arthritis | 6 | 4.3% | 0 | 2 |
| Crohn's disease | 5 | 3.6% | 0 | 1 |
| Diarrhoea | 5 | 3.6% | 0 | 2 |
| Headache | 5 | 3.6% | 0 | 2 |
| Injection site pain | 5 | 3.6% | 0 | 0 |
Other Indications for ADALIMUMAB-AACF
Product used for unknown indication (43)
Rheumatoid arthritis (27)
Crohn's disease (13)
Axial spondyloarthritis (11)
Psoriatic arthropathy (10)
Ankylosing spondylitis (7)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)